A novel machine learning algorithm improved patient selection for CRT in a study of nearly 1,000 heart failure patients, representing an opportunity to optimize care and spare certain individuals from a pricey procedure that might not benefit them.

Short-term opioid prescriptions could have long-term consequences for heart patients with cardiac implantable electronic devices, according to work published in Heart Rhythm Oct. 21.

The Bristol-Myers Squibb-Pfizer Alliance and Fitbit on Oct. 17 announced they’d be partnering to improve timely diagnosis of atrial fibrillation in people at an increased risk of stroke.

An implantable cardiac monitor designed to alert patients with coronary artery disease to progressive, abnormal ST-segment shifts could expedite transport to the ED and reduce treatment delays during acute coronary syndromes, according to work published in the Journal of the American College of Cardiology.

Consuming smaller amounts of alcohol more frequently is a greater risk factor for atrial fibrillation than binge drinking, according to a study published in EP Europace Oct. 17.

Medtronic on Oct. 7 announced the launch of its EV ICD pivotal study—a prospective, pre-market trial designed to assess the efficacy of an extravascular system in treating dangerous arrhythmias.

Doctors at the University of New Mexico Hospital used an extracorporeal membrane oxygenation system to treat a cardiac arrest patient in the field for the first time last week, the Albuquerque Journal reports.

Teens who use or abuse cannabis could be at risk for a number of cardiac arrhythmias, according to research published in the American Journal of Cardiology, including atrial flutter or fibrillation, palpitations and long QT syndrome.